Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo - Roehrborn, C G; Boyle, P; Bergner, D (Urology, 1999)
, et al; PLESS Study Group.